- Treatment of hepatitis C virus (HCV) infection
MYHEP 400MG
| MRP | : |
|
| Price | : | ₹2,500.00 |
| You Save | : | ₹10,113.00 (80.18%) |
28 Tablet(s) In A Bottle
Myhep 400mg Tablet contains Sofosbuvir as its active ingredient. It is a direct-acting antiviral drug utilized for the treatment of hepatitis C virus (HCV) infection. This medication is frequently used in conjunction with other antiviral agents to create a treatment plan that can effectively eradicate HCV from the system. Myhep 400mg Tablet has notably reduced the length of HCV treatment in comparison to previous therapies. It is effective against various genotypes of the hepatitis C virus. This extensive activity makes it a flexible treatment choice suitable for a diverse group of patients infected with different HCV genotypes.
Patients generally tolerate this medication well, with only a few serious side effects reported. Myhep 400mg Tablet should not be administered to individuals with known hypersensitivity or allergic reactions to it or any of its components. This medication is mainly excreted through the kidneys. Consequently, individuals with severe renal impairment may need dosage modifications. It is not authorized for use in children under 18 years of age.
